311 related articles for article (PubMed ID: 32070484)
1. Correlation of Long Noncoding RNA SEMA6A-AS1 Expression with Clinical Outcome in HBV-Related Hepatocellular Carcinoma.
Yu S; Li N; Wang J; Fu Y; Huang Y; Yi P; Chen R; Tang D; Hu X; Fan X
Clin Ther; 2020 Mar; 42(3):439-447. PubMed ID: 32070484
[TBL] [Abstract][Full Text] [Related]
2. Potentials as biomarker and therapeutic target of upregulated long non-coding RNA HLA-F antisense RNA 1 in hepatitis B virus-associated hepatocellular carcinoma.
Zhang X; Li W; Li S; Zhang Z; Song W
Virus Genes; 2024 Jun; 60(3):243-250. PubMed ID: 38568442
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TSPEAR-AS1 predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma and promotes metastasis via miR-1915-5p.
Zhang Y; Wang F; Wang Y
Virus Res; 2022 Jul; 315():198788. PubMed ID: 35477008
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.
Zhang YT; Li BP; Zhang B; Ma P; Wu QL; Ming L; Xie LM
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6333-6341. PubMed ID: 30338801
[TBL] [Abstract][Full Text] [Related]
8. MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells.
Zhong Y; Li Y; Song T; Zhang D
Physiol Genomics; 2019 Oct; 51(10):500-505. PubMed ID: 31251699
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
Luo X; Zhou N; Wang L; Zeng Q; Tang H
Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
[TBL] [Abstract][Full Text] [Related]
11. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.
Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W
Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271
[TBL] [Abstract][Full Text] [Related]
12. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation.
Su Y; Xie R; Xu Q
Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102025. PubMed ID: 36170961
[TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
14. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
16. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
[TBL] [Abstract][Full Text] [Related]
17. lncRNA HAND2-AS1 overexpression inhibits cancer cell proliferation in hepatocellular carcinoma by downregulating RUNX2 expression.
Jing GY; Zheng XZ; Ji XX
J Clin Lab Anal; 2021 Apr; 35(4):e23717. PubMed ID: 33566427
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Eight-lncRNA Prognostic Signature for HBV-HCC and Analysis of Their Functions Based on Coexpression and ceRNA Networks.
Zhao X; Bai Z; Li C; Sheng C; Li H
Biomed Res Int; 2020; 2020():8765461. PubMed ID: 32382578
[TBL] [Abstract][Full Text] [Related]
19. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
